Cargando…

P59. Depleting the suppressors for the benefit of immunotherapy against cervical cancer

Detalles Bibliográficos
Autores principales:	Draghiciu, O, Hoogeboom, BN, Meijerhof, T, Nijman, HW, Daemen, CAHH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072153/ http://dx.doi.org/10.1186/2051-1426-2-S2-P33

Ejemplares similares

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
por: Draghiciu, Oana, et al.
Publicado: (2015)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015)

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development
por: Draghiciu, Oana, et al.
Publicado: (2015)

From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
por: Draghiciu, Oana, et al.
Publicado: (2011)

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7
por: van de Wall, Stephanie, et al.
Publicado: (2015)

P59 - Kartagener syndrome in infant – case report
por: Hristova, Tanya, et al.
Publicado: (2014)

Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[(11)C]Methyl-AMD3465 PET
por: Hartimath, SV, et al.
Publicado: (2019)

House dust mite-specific immunotherapy and tropomyosin sensitizations: harm or benefit for patients?
por: Pevec, B, et al.
Publicado: (2013)

PA01.59. Evaluation of rasayana effect of vayasthapana drugs
por: Ganeshwar Reddy, D Vijay, et al.
Publicado: (2012)

P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
por: Amri, H, et al.
Publicado: (2012)

P59 How COVID-19 influenced UK Burns Services: a national multicentred audit
por: Yoshimura, Ryo, et al.
Publicado: (2021)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
por: Dargel, C, et al.
Publicado: (2014)

Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
por: Hari, BN Vedha, et al.
Publicado: (2012)

YIM-P59. Relationships between the Th17 and innate lymphoid cell signature in enthesitis related arthritis
por: Lom, Hannah, et al.
Publicado: (2014)

Immunotherapy with patient-specific antigens selection reduced the metastasis of a cervical cancer patient
por: Han, Yanyan, et al.
Publicado: (2015)

A59 GLOBAL PROTEOMIC PROFILING OF HUMAN COLONOID MONOLAYERS UNDERGOING IN VITRO CHRONIC DAMAGE
por: Sandilya, S, et al.
Publicado: (2023)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy
por: Molli, Poonam, et al.
Publicado: (2013)

Anaphylaxis during specific subcutaneous immunotherapy against ragweed allergen -- case record
por: Prnjavorac, Besim, et al.
Publicado: (2014)

P05.59. Older adults’ attitudes on collaborative care of low back pain by doctors of chiropractic and medical doctors: a focus group study
por: Lyons, K, et al.
Publicado: (2012)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

P02.48. Overcoming ego depletion: the effects of an optimism manipulation on repeated acts of self-control
por: Meevissen, Y, et al.
Publicado: (2012)

Co-expression of E- and P-cadherin in breast cancer: role as an invasion suppressor or as an invasion promoter?
por: Ribeiro, Ana S, et al.
Publicado: (2010)

High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
por: Ghamande, Sharad, et al.
Publicado: (2015)

Characterisation of the tumour suppressor gene ZAC in breast tissue
por: Valleley, EM, et al.
Publicado: (2006)

Tumor suppressor proteins restricts LINE-1 retrotransposition
por: Kuroki, Misao, et al.
Publicado: (2013)

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
por: Highfill, Steven L, et al.
Publicado: (2013)

PA01.54. Sustainable cultivation of medicinal plants: A multi dimentional solution of global problems
por: Mahapatra, B.N.
Publicado: (2012)

P04.59. National surveys show lower well-being among yogis yet efficacy trials show favorable results: does dose-response resolve the contradiction?
por: Park, C, et al.
Publicado: (2012)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
por: Kaufman, Howard L, et al.
Publicado: (2014)

Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53
por: Fourtouna, A, et al.
Publicado: (2006)

Effect of B cell depletion using peptide tetramers in collagen-induced arthritis
por: Michishita, Kazuya, et al.
Publicado: (2012)

Behavioral effects of disrupted direct pathway signal flow caused by dopamine depletion
por: Summerson, Samantha R, et al.
Publicado: (2013)

Depletion of platelets enhances therapeutic antitumor effects generated by therapeutic DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2013)

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009)

P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection
por: Vieillard, V, et al.
Publicado: (2009)

ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
por: Petit, Robert G, et al.
Publicado: (2014)

Immunologic aspect of ovarian cancer and p53 as tumor antigen
por: Nijman, HW, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ma036upjr9v4r7q93ckd3i2d9v